Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ICCCIMMUCELL CORP /DE/

Nasdaq · CIK 0000811641
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2835 In Vitro & In Vivo Diagnostic Substances
FY end1231
XBRL facts576

Identity from submissions API

NameIMMUCELL CORP /DE/
CIK0000811641
TickersICCC
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2835 In Vitro & In Vivo Diagnostic Substances
EIN010382980
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone2078782770
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
56 EVERGREEN DR
PORTLAND
ME
04103
ME
Mailing address
56 EVERGREEN DRIVE
PORTLAND
ME
04103
ME

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

800 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 8-K/A FORM 8-K/A 9.01 0001437749-26-037731 001-12934 261575004 34 371483 1 1
2026-11-16 4 FORM 4 TE BOEKHORST, OLIVIER 11/16/2026 0001437749-26-037085 7230
2026-11-13 8-K FORM 8-K 2.02,9.01 0001437749-26-036629 001-12934 261548454 34 231716 1 1
2026-11-12 10-Q FORM 10-Q 0001437749-26-036588 001-12934 261547350 34 7650397 1 1
2026-11-12 S-8 FORM S-8 0001437749-26-036507 333-299994 261546129 33 273250 1 1
2026-10-13 8-K FORM 8-K 2.02,9.01 0001437749-26-032465 001-12934 261454273 34 178812 1 1
2026-08-13 10-Q FORM 10-Q 0001437749-26-027668 001-12934 261273348 34 7122729 1 1
2026-08-13 8-K FORM 8-K 2.02,9.01 0001437749-26-027667 001-12934 261273304 34 329934 1 1
2026-07-09 8-K FORM 8-K 2.02,9.01 0001437749-26-023199 001-12934 261165768 34 197608 1 1
2026-06-22 4 FORM 4 TE BOEKHORST, OLIVIER 0001437749-26-021258 4520
2026-06-17 8-K FORM 8-K 5.07,9.01 0001437749-26-020926 001-12934 261097651 34 203545 1 1
2026-06-10 8-K FORM 8-K 7.01,9.01 0001437749-26-020154 001-12934 261079642 34 164842 1 1
2026-05-14 8-K FORM 8-K 2.02,9.01 0001437749-26-017049 001-12934 26978911 34 265014 1 1
2026-05-14 10-Q FORM 10-Q 0001437749-26-017045 001-12934 26978843 34 5862012 1 1
2026-05-13 10-K/A FORM 10-K/A 0001437749-26-016719 001-12934 26973275 34 418472 1 1
2026-05-08 8-K FORM 8-K 1.01 0001437749-26-015945 001-12934 26959447 34 152260 1 1
2026-04-24 DEF 14A FORM DEF 14A 0001437749-26-013234 001-12934 26890511 34 2276532 1 1
2026-04-23 3 FORM 3 DIMARCO, ANTHONY 04/23/26 0001437749-26-013122 4293
2026-04-23 3 FORM 3 GUILLEMETTE, GILLES 04-23-2026 0001437749-26-013118 4304
2026-04-16 4 FORM 4 TURNER, KATHY 04/15/26 0001437749-26-012561 5292
2026-04-16 4 FORM 4, TOMSCHE, DAVID 04/15/26 0001437749-26-012557 5293
2026-04-16 4 FORM 4 BASSE GLORIA 04/15/26 0001437749-26-012554 5280
2026-04-16 4 FORM 4 WAINMAN, PAUL 04/15/26 0001437749-26-012551 5281
2026-04-14 PRE 14A FORM PRE 14A 0001437749-26-012259 001-12934 26861320 34 1910163 1 1
2026-04-14 4 FORM 4 GATHAGAN, BRYAN 04/14/26 0001437749-26-012240 5138
2026-04-14 4 FORM 4 WAINMAN, PAUL 04/16/26 0001437749-26-012238 5042
2026-04-14 4 FORM 4 TOMSCHE, DAVID 04/14/26 0001437749-26-012236 5053
2026-04-14 4 FORM 4 BROCKMANN, BOBBI 04/14/26 0001437749-26-012234 5238
2026-04-14 4 FORM 4 ROSGEN, STEVEN 04/14/26 0001437749-26-012232 5137
2026-04-14 4 FORM 4 BASSE GLORIA 04/14/26 0001437749-26-012230 5041
2026-04-14 8-K FORM 8-K 5.02,8.01,9.01 0001437749-26-012182 001-12934 26858827 34 6826743 1 1
2026-04-08 8-K FORM 8-K 2.02,9.01 0001437749-26-011757 001-12934 26848144 34 189810 1 1
2026-04-01 3 FORM 3 0001437749-26-010820 2835
2026-03-30 10-K FORM 10-K 0001437749-26-010339 001-12934 26813581 34 9544095 1 1
2026-03-24 4 FORM 4 0001437749-26-009661 8199
2026-03-23 4/A FORM 4A 0001437749-26-009312 5893
2026-03-18 8-K FORM 8-K 5.02,9.01 0001437749-26-008842 001-12934 26768908 34 180288 1 1
2026-03-04 8-K FORM 8-K 2.02,9.01 0001437749-26-006912 001-12934 26721236 34 240548 1 1
2026-02-09 8-K FORM 8-K 5.02,9.01 0001437749-26-003514 001-12934 26611494 34 158824 1 1
2026-02-02 8-K FORM 8-K 1.01,5.02,9.01 0001437749-26-002685 001-12934 26589007 34 403839 1 1
2026-01-29 4 FORM 4 FIORI 0001437749-26-002371 5306
2026-01-29 4 FORM 4 BROCKMANN 0001437749-26-002369 5499
2026-01-29 4 FORM 4 TE BOEKHORST 0001437749-26-002366 5460
2026-01-08 8-K FORM 8-K 2.02,2.06,8.01,9.01 0001437749-26-000885 001-12934 26519751 34 217089 1 1
2025-12-29 8-K FORM 8-K 2.06,8.01,9.01 0001437749-25-038773 001-12934 251603146 34 190234 1 1
2025-12-04 4/A FORM 4/A OLIVIER TE BOEKHORST 0001437749-25-036913 6240
2025-12-03 4 FORM 4 O TE BOEKHORST 0001437749-25-036794 7041
2025-11-28 4 FORM 4 D TOMSCHE 0001437749-25-036477 6355
2025-11-20 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-25-289897 005-39373 251503525 34 9583
2025-11-13 10-Q FORM 10-Q 0001437749-25-034817 001-12934 251478467 34 11181485 1 1
2025-11-13 8-K FORM 8-K 2.02,9.01 0001437749-25-034819 001-12934 251478447 34 244935 1 1
2025-11-12 4 FORM 4 0001437749-25-034257 5468
2025-11-07 3 FORM 3 O. TE BOEKHORST 0001437749-25-033705 6291
2025-11-04 8-K FORM 8-K 5.02,9.01 0001437749-25-033017 001-12934 251449037 34 182686 1 1
2025-10-07 8-K FORM 8-K EARNINGS 2.02,9.01 0001437749-25-030631 001-12934 251379878 34 189420 1 1
2025-09-30 8-K FORM 8-K 1.01,5.02,9.01 0001437749-25-030110 001-12934 251360415 34 328780 1 1
2025-08-25 8-K CURRENT REPORT 1.01,2.03,9.01 0001213900-25-080110 001-12934 251247938 34 205557 1 1
2025-08-14 10-Q QUARTERLY REPORT 0001213900-25-076635 001-12934 251218856 34 7334609 1 1
2025-08-14 8-K CURRENT REPORT 2.02,9.01 0001213900-25-076633 001-12934 251218818 34 320685 1 1
2025-08-12 8-K CURRENT REPORT 1.01,2.03,9.01 0001213900-25-074983 001-12934 251207050 34 569400 1 1
2025-07-09 8-K CURRENT REPORT 2.02,9.01 0001213900-25-062192 001-12934 251112300 34 223506 1 1
2025-06-25 8-K CURRENT REPORT 8.01,9.01 0001213900-25-057768 001-12934 251073486 34 200608 1 1
2025-06-17 8-K CURRENT REPORT 5.07 0001213900-25-055144 001-12934 251052969 34 203618 1 1
2025-06-13 4 PRIMARY DOCUMENT 0001213900-25-054188 9418
2025-06-12 4 PRIMARY DOCUMENT 0001213900-25-053904 4747
2025-05-14 10-Q QUARTERLY REPORT 0001213900-25-043287 001-12934 25945364 34 6630534 1 1
2025-05-14 8-K CURRENT REPORT 2.02,9.01 0001213900-25-043290 001-12934 25945312 34 265195 1 1
2025-04-24 DEF 14A PROXY STATEMENT 0001213900-25-035059 001-12934 25867356 34 2754512 1 1
2025-04-23 4 PRIMARY DOCUMENT 0001213900-25-034500 5248
2025-04-08 8-K CURRENT REPORT 2.02,9.01 0001213900-25-029914 001-12934 25821932 34 227409 1 1
2025-04-07 3 PRIMARY DOCUMENT 0001213900-25-029424 3056
2025-04-07 8-K CURRENT REPORT 1.01,5.02,9.01 0001213900-25-029407 001-12934 25818123 34 251310 1 1
2025-03-28 10-K ANNUAL REPORT 0001013762-25-004072 001-12934 25785916 34 8431119 1 1
2025-02-25 8-K CURRENT REPORT 2.02,9.01 0001213900-25-017067 001-12934 25662993 34 276581 1 1
2025-01-16 8-K CURRENT REPORT 8.01,9.01 0001213900-25-004200 001-12934 25535753 34 236345 1 1
2025-01-10 8-K CURRENT REPORT 2.02,9.01 0001213900-25-002326 001-12934 25520374 34 225670 1 1
2024-12-09 8-K CURRENT REPORT 1.01,1.02,5.02,9.01 0001213900-24-106933 001-12934 241535247 34 243053 1 1
2024-12-02 8-K CURRENT REPORT 1.01,9.01 0001213900-24-104543 001-12934 241519007 34 225332 1 1
2024-11-13 10-Q QUARTERLY REPORT 0001213900-24-097450 001-12934 241454048 34 8276560 1 1
2024-11-13 8-K CURRENT REPORT 2.02,9.01 0001213900-24-097449 001-12934 241453972 34 322046 1 1
2024-10-08 8-K CURRENT REPORT 2.02,9.01 0001213900-24-086275 001-12934 241360364 34 224446 1 1
2024-09-24 8-K CURRENT REPORT 1.01,2.03,5.03,9.01 0001213900-24-081304 001-12934 241318461 34 364612 1 1
2024-09-24 4 PRIMARY DOCUMENT 0001213900-24-081210 5273
2024-09-24 4 PRIMARY DOCUMENT 0001213900-24-081209 5271
2024-09-24 4 PRIMARY DOCUMENT 0001213900-24-081207 5281
2024-09-24 4 PRIMARY DOCUMENT 0001213900-24-081206 5351
2024-09-24 4 PRIMARY DOCUMENT 0001213900-24-081205 5313
2024-09-17 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001744329-24-000005 005-39373 241303527 34 11908
2024-08-30 4 PRIMARY DOCUMENT 0001213900-24-074326 4772
2024-08-27 SC 13D SC 13D 0001193125-24-207799 005-39373 241249542 34 35122
2024-08-26 4 PRIMARY DOCUMENT 0001213900-24-072552 4772
2024-08-22 4 PRIMARY DOCUMENT 0001213900-24-071759 4773
2024-08-19 4 PRIMARY DOCUMENT 0001213900-24-070559 7794
2024-08-13 10-Q QUARTERLY REPORT 0001213900-24-068245 001-12934 241201372 34 7865196 1 1
2024-08-13 8-K CURRENT REPORT 2.02,9.01 0001213900-24-068243 001-12934 241201351 34 290493 1 1
2024-07-09 8-K CURRENT REPORT 2.02,9.01 0001213900-24-060121 001-12934 241107498 34 224704 1 1
2024-06-14 8-K CURRENT REPORT 1.01,2.03,9.01 0001213900-24-052776 001-12934 241044050 34 213430 1 1
2024-06-14 8-K CURRENT REPORT 5.07 0001213900-24-052706 001-12934 241043619 34 206853 1 1
2024-06-06 8-K CURRENT REPORT 8.01,9.01 0001213900-24-050197 001-12934 241023861 34 217004 1 1
2024-05-22 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001744329-24-000003 005-39373 24974088 34 21589
2024-05-14 10-Q QUARTERLY REPORT 0001213900-24-042925 001-12934 24944262 34 7359833 1 1
2024-05-14 8-K CURRENT REPORT 2.02,9.01 0001213900-24-042926 001-12934 24944242 34 258482 1 1
2024-04-26 DEF 14A PROXY STATEMENT 0001213900-24-036378 001-12934 24879074 34 1593865
2024-04-10 424B2 PROSPECTUS 0001213900-24-031689 333-278438 24833959 33 95983
2024-04-10 424B2 PROSPECTUS 0001213900-24-031688 333-278438 24833957 33 108555
2024-04-09 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-04-09 17:00:00 9999999995-24-000907 333-278438 24834112 33 1710
2024-04-09 8-K CURRENT REPORT 1.01,9.01 0001213900-24-031647 001-12934 24833577 34 505074 1 1
2024-04-09 8-K CURRENT REPORT 2.02,9.01 0001213900-24-031589 001-12934 24832716 34 233927 1 1
2024-04-05 CORRESP filename1.htm 0001213900-24-030781 9621
2024-04-05 UPLOAD filename1.pdf 0000000000-24-003677 333-278438 40214
2024-04-01 S-3 REGISTRATION STATEMENT 0001213900-24-028881 333-278438 24810826 33 371271
2024-04-01 10-K ANNUAL REPORT 0001213900-24-028718 001-12934 24809132 34 9138328 1 1
2024-03-06 8-K CURRENT REPORT 1.01,9.01 0001213900-24-020389 001-12934 24725264 34 235314 1 1
2024-02-27 8-K CURRENT REPORT 1.01,2.03,9.01 0001213900-24-017522 001-12934 24686488 34 229494 1 1
2024-02-27 8-K CURRENT REPORT 2.02,9.01 0001213900-24-017520 001-12934 24686491 34 271280 1 1
2024-01-08 8-K CURRENT REPORT 2.02,9.01 0001213900-24-001894 001-12934 24520073 34 228899 1 1
2023-11-16 8-K CURRENT REPORT 1.01,2.03,9.01 0001213900-23-087893 001-12934 231414340 34 224415 1 1
2023-11-13 10-Q QUARTERLY REPORT 0001213900-23-086092 001-12934 231398606 34 7302875 1 1
2023-11-13 8-K CURRENT REPORT 2.02,9.01 0001213900-23-086101 001-12934 231398601 34 269829 1 1
2023-10-05 8-K CURRENT REPORT 2.02,9.01 0001013762-23-002136 001-12934 231311364 34 229025 1 1
2023-09-06 4 PRIMARY DOCUMENT 0001213900-23-074246 4691
2023-08-30 4 PRIMARY DOCUMENT 0001213900-23-072079 5269
2023-08-10 10-Q QUARTERLY REPORT 0001213900-23-065595 001-12934 231159310 34 6912183 1 1
2023-08-10 8-K CURRENT REPORT 2.02,9.01 0001213900-23-065597 001-12934 231159262 34 291136 1 1
2023-07-21 8-K CURRENT REPORT 1.01,2.03,9.01 0001213900-23-058672 001-12934 231101207 34 535519 1 1
2023-07-13 S-8 REGISTRATION STATEMENT 0001213900-23-056706 333-273227 231086497 33 107086
2023-07-11 8-K CURRENT REPORT 2.02,9.01 0001213900-23-056198 001-12934 231082213 34 233472 1 1
2023-06-29 8-K CURRENT REPORT 7.01,9.01 0001213900-23-052780 001-12934 231056168 34 209556 1 1
2023-06-21 3 PRIMARY DOCUMENT 0001213900-23-050501 3047
2023-06-21 8-K CURRENT REPORT 5.02,5.07,9.01 0001213900-23-050488 001-12934 231029810 34 255838 1 1
2023-05-11 8-K CURRENT REPORT 2.02,9.01 0001213900-23-038528 001-12934 23910943 34 255783 1 1
2023-05-11 10-Q QUARTERLY REPORT 0001213900-23-038529 001-12934 23910930 34 7864018 1 1
2023-04-28 ARS ANNUAL REPORT 0001213900-23-033562 001-12934 23861285 34 408521
2023-04-28 DEF 14A PROXY STATEMENT 0001213900-23-033559 001-12934 23861252 34 1616023
2023-04-18 PRE 14A PROXY STATEMENT 0001213900-23-030733 001-12934 23827691 34 1553041
2023-04-05 8-K CURRENT REPORT 2.02,9.01 0001213900-23-027540 001-12934 23802509 34 225671 1 1
2023-03-29 10-K ANNUAL REPORT 0001213900-23-024080 001-12934 23775234 34 7370929 1 1
2023-03-15 4 PRIMARY DOCUMENT 0001213900-23-020267 40839
2023-02-28 8-K CURRENT REPORT 5.02 0001213900-23-015065 001-12934 23678986 34 194403 1 1
2023-02-21 8-K CURRENT REPORT 2.02,9.01 0001213900-23-013281 001-12934 23648093 34 261499 1 1
2023-02-01 8-K CURRENT REPORT 5.02 0001213900-23-006754 001-12934 23577917 34 204797 1 1
2023-01-24 4 xslF345X03/ownership.xml 0001213900-23-004914 5054
2023-01-24 4 xslF345X03/ownership.xml 0001213900-23-004913 5064
2023-01-24 4 xslF345X03/ownership.xml 0001213900-23-004912 5094
2023-01-24 4 xslF345X03/ownership.xml 0001213900-23-004910 5058
2023-01-24 4 xslF345X03/ownership.xml 0001213900-23-004909 5054
2023-01-24 3 xslF345X02/ownership.xml 0001213900-23-004796 2796
2023-01-09 8-K CURRENT REPORT 2.02,9.01 0001213900-23-001673 001-12934 23518204 34 230713 1 1
2022-11-21 8-K CURRENT REPORT 2.02,9.01 0001213900-22-074266 001-12934 221406520 34 276575 1 1
2022-11-21 10-Q QUARTERLY REPORT 0001213900-22-074215 001-12934 221405797 34 7128095 1 1
2022-11-21 10-Q/A AMENDMENT NO. 1 TO FORM 10-Q 0001213900-22-074052 001-12934 221403798 34 7594403 1 1
2022-11-21 10-Q/A AMENDMENT NO. 1 TO FORM 10-Q 0001213900-22-074049 001-12934 221403795 34 7184425 1 1
2022-11-10 8-K CURRENT REPORT 2.02,4.02,9.01 0001213900-22-071209 001-12934 221377632 34 225367 1 1
2022-11-10 NT 10-Q NOTIFICATION OF LATE FILING 0001213900-22-071204 001-12934 221377595 34 26836
2022-10-05 8-K CURRENT REPORT 2.02,9.01 0001213900-22-062089 001-12934 221294494 34 225471 1 1
2022-09-12 4 PRIMARY DOCUMENT 0001213900-22-055334 20942
2022-08-17 8-K CURRENT REPORT 1.01,2.03,9.01 0001213900-22-049025 001-12934 221174661 34 239781 1 1
2022-08-11 10-Q QUARTERLY REPORT 0001213900-22-046861 001-12934 221155707 34 6712065 1 1
2022-08-11 8-K CURRENT REPORT 2.02,9.01 0001213900-22-046860 001-12934 221155651 34 282691 1 1
2022-07-28 8-K CURRENT REPORT 8.01,9.01 0001213900-22-042127 001-12934 221112374 34 222184 1 1
2022-07-07 8-K CURRENT REPORT 2.02,9.01 0001213900-22-037699 001-12934 221070044 34 227976 1 1
2022-06-21 8-K/A AMENDMENT NO. 1 TO FORM 8-K 5.07 0001213900-22-033723 001-12934 221025907 34 226152 1 1
2022-06-16 4 PRIMARY DOCUMENT 0001213900-22-033261 33682
2022-06-16 8-K CURRENT REPORT 5.07 0001213900-22-033210 001-12934 221019657 34 217937 1 1
2022-06-14 4 PRIMARY DOCUMENT 0001213900-22-032625 4688
2022-05-18 4/A xslF345X03/ownership.xml 0001213900-22-028008 6065
2022-05-18 4 xslF345X03/ownership.xml 0001213900-22-028004 2817
2022-05-18 4 PRIMARY DOCUMENT 0001213900-22-027891 6425
2022-05-12 10-Q QUARTERLY REPORT 0001213900-22-025936 001-12934 22917764 34 6208999 1 1
2022-05-12 8-K CURRENT REPORT 2.02,9.01 0001213900-22-025932 001-12934 22917727 34 263137 1 1
2022-04-28 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-22-022120 001-12934 22862347 34 782837
2022-04-12 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-22-019300 001-12934 22821179 34 236995
2022-04-11 8-K CURRENT REPORT 2.02,9.01 0001213900-22-019175 001-12934 22819510 34 226813 1 1
2022-03-30 10-K ANNUAL REPORT 0001213900-22-016147 001-12934 22786431 34 6837953 1 1
2022-03-24 8-K CURRENT REPORT 1.01,2.03,9.01 0001213900-22-014793 001-12934 22766035 34 231125 1 1
2022-03-14 4 PRIMARY DOCUMENT 0001213900-22-012143 4697
2022-02-22 8-K CURRENT REPORT 2.02,9.01 0001213900-22-008685 001-12934 22658070 34 262621 1 1
2022-02-11 8-K CURRENT REPORT 1.01,5.02,9.01 0001213900-22-006916 001-12934 22619405 34 248895 1 1
2022-02-09 4 PRIMARY DOCUMENT 0001213900-22-006179 5440
2022-02-09 4 PRIMARY DOCUMENT 0001213900-22-006175 5615
2022-02-09 4 PRIMARY DOCUMENT 0001213900-22-006147 5688
2022-01-05 8-K CURRENT REPORT 2.02,9.01 0001213900-22-000644 001-12934 22509815 34 239273 1 1
2021-11-15 8-K CURRENT REPORT 2.02,9.01 0001213900-21-059340 001-12934 211410339 34 270330 1 1
2021-11-15 10-Q QUARTERLY REPORT 0001213900-21-059332 001-12934 211410333 34 6350529 1 1
2021-10-06 8-K CURRENT REPORT 2.02,9.01 0001213900-21-051533 001-12934 211308977 34 231654 1 1
2021-08-24 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-21-044571 001-12934 211202088 34 212749 1 1
2021-08-12 10-Q QUARTERLY REPORT 0001213900-21-042017 001-12934 211167556 34 6300965 1 1
2021-08-12 8-K CURRENT REPORT 2.02,9.01 0001213900-21-042009 001-12934 211167467 34 88046
2021-07-07 8-K CURRENT REPORT 2.02,9.01 0001213900-21-035925 001-12934 211077157 34 30680
2021-07-06 8-K CURRENT REPORT 1.01,2.03,9.01 0001213900-21-035662 001-12934 211072461 34 164827
2021-06-25 4 xslF345X03/ownership.xml 0001213900-21-034084 7249
2021-06-21 4 xslF345X03/ownership.xml 0001213900-21-033251 5092
2021-06-21 4 xslF345X03/ownership.xml 0001213900-21-033249 5056
2021-06-21 4 xslF345X03/ownership.xml 0001213900-21-033246 5062
2021-06-21 4 xslF345X03/ownership.xml 0001213900-21-033244 5052
2021-06-17 8-K CURRENT REPORT 5.07 0001213900-21-032937 001-12934 211024393 34 41916
2021-06-07 4 xslF345X03/ownership.xml 0001213900-21-031186 6930
2021-05-13 10-Q QUARTERLY REPORT 0001213900-21-026068 001-12934 21919625 34 4667469 1
2021-05-13 8-K CURRENT REPORT 2.02,9.01 0001213900-21-026061 001-12934 21919569 34 63169
2021-04-29 DEF 14A PROXY STATEMENT 0001213900-21-023398 001-12934 21867349 34 701831
2021-04-16 SC 13D/A SC 13D/A 0001140361-21-013074 005-39373 21831294 34 115539
2021-04-16 424B5 PROSPECTUS SUPPLEMENT 0001213900-21-021847 333-228479 21830677 33 260021
2021-04-15 8-K CURRENT REPORT 1.01,9.01 0001213900-21-021672 001-12934 21828089 34 219813
2021-04-07 8-K FORM 8-K 2.02,9.01 0001213900-21-020553 001-12934 21811052 34 32160
2021-03-30 10-K ANNUAL REPORT 0001213900-21-018473 001-12934 21783666 34 5152482 1
2021-02-23 8-K CURRENT REPORT 2.02,9.01 0001213900-21-011088 001-12934 21664625 34 84050
2021-02-04 SC 13G/A SEC SCHEDULE 13G 0000902219-21-000258 005-39373 21589746 34 32673
2021-02-03 SC 13G/A SEC SCHEDULE 13G 0001450835-21-000038 005-39373 21584659 34 18936
2021-02-03 SC 13G/A SEC SCHEDULE 13G 0001450835-21-000017 005-39373 21584591 34 19202
2021-01-07 8-K CURRENT REPORT 2.02,9.01 0001213900-21-000823 001-12934 21513255 34 44597
2020-12-17 8-K CURRENT REPORT 1.01,2.03,9.01 0001213900-20-043105 001-12934 201393458 34 222099
2020-12-11 4 PRIMARY DOCUMENT 0001213900-20-042167 7192
2020-11-12 8-K CURRENT REPORT 2.02,9.01 0001213900-20-036561 001-12934 201307109 34 84240
2020-11-12 10-Q QUARTERLY REPORT 0001213900-20-036536 001-12934 201306680 34 4874165 1
2020-10-06 8-K CURRENT REPORT 2.02,9.01 0001213900-20-030229 001-12934 201225984 34 41735
2020-08-12 10-Q QUARTERLY REPORT 0001213900-20-021605 001-12934 201095446 34 6257246 1
2020-08-12 8-K FORM 8-K 2.02,9.01 0001213900-20-021604 001-12934 201095419 34 78955
2020-07-07 8-K CURRENT REPORT 2.02,9.01 0001213900-20-016833 001-12934 201015354 34 46989
2020-06-16 8-K CURRENT REPORT 1.01,2.03,9.01 0001213900-20-015079 001-12934 20965388 34 224181
2020-06-11 8-K FORM 8-K 5.03,5.07,9.01 0001213900-20-014682 001-12934 20957106 34 46141
2020-05-15 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-20-012432 001-12934 20881238 34 42531
2020-05-14 8-K CURRENT REPORT 8.01,9.01 0001213900-20-012155 001-12934 20876409 34 34602
2020-05-13 8-K FORM 8-K 2.02,9.01 0001213900-20-011998 001-12934 20873494 34 60971
2020-05-13 10-Q QUARTERLY REPORT 0001213900-20-011986 001-12934 20873151 34 4261876 1
2020-04-28 DEF 14A PROXY STATEMENT 0001213900-20-010227 001-12934 20822132 34 709987
2020-04-14 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-20-009125 001-12934 20790172 34 245265
2020-04-14 8-K CURRENT REPORT 1.01,2.03 0001213900-20-009122 001-12934 20790152 34 93205
2020-04-02 8-K CURRENT REPORT 2.02,9.01 0001213900-20-008463 001-12934 20769792 34 38528
2020-03-27 10-K ANNUAL REPORT 0001213900-20-007650 001-12934 20751228 34 5163874 1
2020-03-27 S-8 REGISTRATION STATEMENT 0001213900-20-007608 333-237428 20749098 33 204203
2020-03-12 4 PRIMARY DOCUMENT 0001213900-20-006134 4688
2020-03-12 8-K CURRENT REPORT 1.01,2.03 0001213900-20-006089 001-12934 20708164 34 454760
2020-03-12 4 PRIMARY DOCUMENT 0001213900-20-006079 4881
2020-03-02 4 PRIMARY DOCUMENT 0001213900-20-005102 4881
2020-02-19 8-K/A CURRENT REPORT 2.02,9.01 0001213900-20-004204 001-12934 20628422 34 35717
2020-02-18 8-K CURRENT REPORT 2.02,9.01 0001213900-20-004129 001-12934 20625422 34 78269
2020-01-29 SC 13G SEC SCHEDULE 13G 0000846087-20-000016 005-39373 20556731 34 19427
2020-01-28 SC 13G SEC SCHEDULE 13G 0000902219-20-000212 005-39373 20551710 34 37194
2020-01-22 8-K CURRENT REPORT 2.02,9.01 0001213900-20-001525 001-12934 20538124 34 56385
2019-12-12 4 PRIMARY DOCUMENT 0001213900-19-025996 5430
2019-12-12 4 PRIMARY DOCUMENT 0001213900-19-025994 13665
2019-11-12 10-Q QUARTERLY REPORT 0001213900-19-022739 001-12934 191206228 34 4676479 1
2019-11-12 8-K CURRENT REPORT 2.02,9.01 0001213900-19-022667 001-12934 191205566 34 79582
2019-09-17 8-K CURRENT REPORT 1.01,9.01 0001213900-19-018253 001-12934 191095998 34 338561
2019-09-11 8-K CURRENT REPORT 1.01,1.02,9.01 0001213900-19-017687 001-12934 191087506 34 166380
2019-08-29 8-K FORM 8-K 8.01,9.01 0001213900-19-016898 001-12934 191063631 34 29996
2019-08-12 10-Q QUARTERLY REPORT 0001213900-19-015331 001-12934 191016553 34 4617152 1
2019-08-12 8-K 8-K 2.02,9.01 0001213900-19-015333 001-12934 191016547 34 76085
2019-06-18 8-K CURRENT REPORT 5.07 0001213900-19-010939 001-12934 19903620 34 46408
2019-05-13 10-Q QUARTERLY REPORT 0001213900-19-008423 001-12934 19818436 34 4428737 1
2019-05-13 8-K CURRENT REPORT 2.02,9.01 0001213900-19-008421 001-12934 19818369 34 60451
2019-05-10 DEFR14A DEFINITIVE PROXY STATEMENT 0001213900-19-008209 001-12934 19812911 34 60337
2019-04-29 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-19-007272 001-12934 19773786 34 188777
2019-04-12 8-K CURRENT REPORT 4.01,9.01 0001213900-19-006268 001-12934 19746443 34 34282
2019-04-12 8-K CURRENT REPORT 1.01,9.01 0001213900-19-006241 001-12934 19745623 34 29525
2019-04-08 SC 13G SEC SCHEDULE 13G 0000846087-19-000061 005-39373 19736708 34 18947
2019-04-01 SC 13D/A AMENDMENT NO. 5 TO SCHEDULE 13D 0001213900-19-005423 005-39373 19719990 34 56826
2019-03-29 8-K CURRENT REPORT 1.01,7.01,9.01 0001213900-19-005210 001-12934 19715426 34 336820
2019-03-28 SC 13D/A SC 13D/A 0001140361-19-005801 005-39373 19710410 34 122519
2019-03-27 424B5 f424b5_immucell.htm 0001213900-19-004959 333-228479 19709095 33 304772
2019-03-26 424B5 f424b5_immucell.htm 0001213900-19-004861 333-228479 19705443 33 296507
2019-03-22 10-K ANNUAL REPORT 0001213900-19-004653 001-12934 19698505 34 6753882 1
2019-03-13 4 PRIMARY DOCUMENT 0001213900-19-004013 7097
2019-03-01 8-K CURRENT REPORT 8.01,9.01 0001213900-19-003385 001-12934 19647056 34 36848
2019-02-13 8-K CURRENT REPORT 2.02,9.01 0001213900-19-002347 001-12934 19597089 34 97416
2018-12-28 4 PRIMARY DOCUMENT 0001213900-18-017963 7026
2018-12-11 8-K CURRENT REPORT 8.01,9.01 0001213900-18-017200 001-12934 181228688 34 38001
2018-11-29 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2018-11-29 17:00:00 9999999995-18-003000 333-228479 181209765 33 1662
2018-11-29 424B3 PROSPECTUS SUPPLEMENT 0001213900-18-016742 333-228479 181209256 33 110983
2018-11-28 CORRESP filename1.htm 0001213900-18-016645 7753
2018-11-27 4 PRIMARY DOCUMENT 0001213900-18-016587 8852
2018-11-26 UPLOAD filename1.pdf 0000000000-18-036172 45949
2018-11-20 S-3 REGISTRATION STATEMENT 0001213900-18-016275 333-228479 181194924 33 256218
2018-11-13 8-K CURRENT REPORT 2.02,9.01 0001213900-18-015496 001-12934 181177995 34 87117
2018-11-13 10-Q QUARTERLY REPORT 0001213900-18-015491 001-12934 181177898 34 4905961 1
2018-09-26 8-K CURRENT REPORT 8.01,9.01 0001213900-18-013004 001-12934 181086534 34 34276
2018-08-20 4 PRIMARY DOCUMENT 0001213900-18-011407 4882
2018-08-16 4 PRIMARY DOCUMENT 0001213900-18-011272 4688
2018-08-13 8-K CURRENT REPORT 2.02,9.01 0001213900-18-010826 001-12934 181012597 34 82696
2018-08-13 10-Q QUARTERLY REPORT 0001213900-18-010819 001-12934 181012330 34 4826071 1
2018-07-25 8-K CURRENT REPORT 8.01,9.01 0001213900-18-009596 001-12934 18967702 34 35739
2018-07-10 8-K CURRENT REPORT 2.02,9.01 0001213900-18-008958 001-12934 18945848 34 49524
2018-06-18 8-K CURRENT REPORT 5.03,5.07,9.01 0001213900-18-007801 001-12934 18905130 34 111812
2018-05-14 10-Q QUARTERLY REPORT 0001213900-18-006104 001-12934 18830561 34 4903319 1
2018-05-14 8-K f8k051418_immucell.htm 2.02,9.01 0001213900-18-006105 001-12934 18830556 34 66815
2018-04-30 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-18-005113 001-12934 18786852 34 516429
2018-04-16 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-18-004537 001-12934 18757331 34 283638
2018-03-29 10-K ANNUAL REPORT 0001213900-18-003621 001-12934 18721203 34 6090353 1
2018-03-21 4 PRIMARY DOCUMENT 0001213900-18-003258 5324
2018-03-21 4 PRIMARY DOCUMENT 0001213900-18-003257 5320
2018-03-21 4 PRIMARY DOCUMENT 0001213900-18-003256 5365
2018-03-21 4 PRIMARY DOCUMENT 0001213900-18-003255 5360
2018-03-21 4 PRIMARY DOCUMENT 0001213900-18-003254 5330
2018-03-21 4 PRIMARY DOCUMENT 0001213900-18-003253 5330
2018-02-08 8-K CURRENT REPORT 2.02,9.01 0001213900-18-001448 001-12934 18585804 34 82394
2018-02-01 8-K CURRENT REPORT 5.02,9.01 0001213900-18-001142 001-12934 18566201 34 32728
2018-02-01 3 PRIMARY DOCUMENT 0001213900-18-001131 2905
2018-01-10 4 PRIMARY DOCUMENT 0001213900-18-000338 5266
2018-01-10 4 PRIMARY DOCUMENT 0001213900-18-000337 5335
2018-01-10 4 PRIMARY DOCUMENT 0001213900-18-000336 5319
2017-12-21 8-K CURRENT REPORT 8.01,9.01 0001213900-17-013524 001-12934 171269462 34 251478
2017-12-19 424B5 PROSPECTUS SUPPLEMENT 0001213900-17-013430 333-207635 171264889 33 343673
2017-12-19 8-K CURRENT REPORT 1.01,2.02,7.01,9.01 0001213900-17-013397 001-12934 171262845 34 57121
2017-11-13 10-Q QUARTERLY REPORT 0001213900-17-011859 001-12934 171196407 34 5034968 1
2017-11-13 8-K CURRENT REPORT 2.02,9.01 0001213900-17-011849 001-12934 171196011 34 88478
2017-11-13 8-K CURRENT REPORT 8.01,9.01 0001213900-17-011799 001-12934 171194282 34 35794
2017-09-19 SC 13D/A AMENDMENT NO. 4 TO SCHEDULE 13D 0001213900-17-009816 005-39373 171091256 34 54071
2017-09-05 8-K CURRENT REPORT 5.02,9.01 0001213900-17-009411 001-12934 171067368 34 35871
2017-08-22 8-K FORM 8-K 3.01 0001213900-17-009054 001-12934 171045229 34 14666
2017-08-14 4 OWNERSHIP DOCUMENT 0001213900-17-008732 3781
2017-08-14 10-Q QUARTERLY REPORT 0001213900-17-008652 001-12934 171030421 34 5099478 1
2017-08-14 8-K CURRENT REPORT 2.02,9.01 0001213900-17-008650 001-12934 171030099 34 107578
2017-08-14 8-K CURRENT REPORT 5.02,9.01 0001213900-17-008560 001-12934 171027842 34 25167
2017-07-31 SC 13D/A SC 13DA 0001140361-17-029260 005-39373 17991890 34 102087
2017-07-28 4 OWNERSHIP DOCUMENT 0000921895-17-002000 6117
2017-07-28 4 OWNERSHIP DOCUMENT 0000921895-17-001998 4705
2017-07-27 8-K/A CURRENT REPORT 1.01,9.01 0001213900-17-007984 001-12934 17987092 34 258430 1 1
2017-07-27 424B5 PROSPECTUS SUPPLEMENT 0001213900-17-007981 333-207635 17987033 33 314290
2017-07-27 8-K CURRENT REPORT 1.01,9.01 0001213900-17-007972 001-12934 17986334 34 270454 1 1
2017-07-25 8-K CURRENT REPORT 1.01 0001213900-17-007886 001-12934 17979585 34 19504
2017-07-14 8-K FORM 8-K 5.03,8.01,9.01 0001171843-17-004091 001-12934 17965764 34 19236
2017-06-16 8-K CURRENT REPORT 5.07 0001213900-17-006566 001-12934 17915879 34 49828
2017-05-11 10-Q QUARTERLY REPORT 0001213900-17-004937 001-12934 17834292 34 4748421 1
2017-05-11 8-K CURRENT REPORT 2.02,9.01 0001213900-17-004938 001-12934 17834277 34 63196
2017-04-28 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-17-004340 001-12934 17791709 34 1320576
2017-03-30 10-K ANNUAL REPORT 0001213900-17-003009 001-12934 17725534 34 6917217 1
2017-03-21 4 PRIMARY DOCUMENT 0001547522-17-000042 6917
2017-03-15 4 PRIMARY DOCUMENT 0001547522-17-000040 11242
2017-03-08 8-K IMMUCELL CORPORATION 8-K 1.01,5.02 0001102624-17-000132 001-12934 17674528 34 50946
2017-03-02 8-K IMMUCELL CORPORATION 8-K 1.01,8.01,9.01 0001102624-17-000110 001-12934 17657632 34 18448
2017-02-14 4 PRIMARY DOCUMENT 0001547522-17-000034 5292
2017-02-14 4 PRIMARY DOCUMENT 0001547522-17-000019 5270
2017-02-14 4 PRIMARY DOCUMENT 0001547522-17-000017 5247
2017-02-14 4 PRIMARY DOCUMENT 0001547522-17-000016 7607
2017-02-10 8-K IMMUCELL CORPORATION 8-K 2.02,9.01 0001102624-17-000078 001-12934 17589627 34 28186
2017-01-25 SC 13G/A NORTHPOINTE CAPITAL LLC 0001085146-17-000181 005-39373 17545352 34 27447
2016-12-15 424B3 PROSPECTUS 0001213900-16-019433 333-214641 162052437 33 240410
2016-12-14 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2016-12-14 17:00:00 9999999995-16-006451 333-214641 162052272 33 1662
2016-12-14 CORRESP filename1.htm 0001213900-16-019413 8038
2016-12-05 S-3/A AMENDMENT TO FORM S-3 0001213900-16-019154 333-214641 162034264 33 486802
2016-11-28 UPLOAD filename1.pdf 0000000000-16-102464 137071
2016-11-16 S-3 REGISTRATION STATEMENT 0001213900-16-018648 333-214641 162002182 33 322818
2016-11-10 10-Q QUARTERLY REPORT 0001213900-16-018201 001-12934 161988432 34 16027324 1
2016-11-10 8-K IMMUCELL CORPORATION 8-K 9.01 0001102624-16-003628 001-12934 161988047 34 26235
2016-11-08 4 PRIMARY DOCUMENT 0001547522-16-000320 4755
2016-10-27 3 OWNERSHIP DOCUMENT 0000921895-16-005937 3785
2016-10-27 3 OWNERSHIP DOCUMENT 0000921895-16-005936 3855
2016-10-26 SC 13D/A NORMAN H PESSIN SC 13DA 10-25-2016 (IMMUCELL CORPORATION) 0001140361-16-083572 005-39373 161951736 34 87664
2016-10-24 D xslFormDX01/primary_doc.xml 06b 0001213900-16-017672 021-273064 161947564 33 12814
2016-10-21 8-K IMMUCELL CORPORATION 8-K 1.01,9.01 0001102624-16-003505 001-12934 161945948 34 402410
2016-10-18 8-K IMMUCELL CORPORATION 8-K 1.01,9.01 0001102624-16-003496 001-12934 161939907 34 19632
2016-10-18 8-K IMMUCELL CORPORATION 8-K 2.02,8.01,9.01 0001102624-16-003495 001-12934 161939868 34 23850
2016-10-11 8-K IMMUCELL CORPORATION 8-K 1.01,8.01,9.01 0001102624-16-003461 001-12934 161930459 34 21897
2016-09-21 4 PRIMARY DOCUMENT 0001547522-16-000302 8734
2016-08-22 4 PRIMARY DOCUMENT 0001547522-16-000287 4578
2016-08-22 4 PRIMARY DOCUMENT 0001547522-16-000285 6880
2016-08-11 10-Q QUARTERLY REPORT 0001213900-16-015764 001-12934 161824629 34 4260669 1
2016-08-11 8-K IMMUCELL CORPORATION 8-K 9.01 0001102624-16-003269 001-12934 161824624 34 26438
2016-07-12 4 PRIMARY DOCUMENT 0001547522-16-000257 13663
2016-07-07 4 PRIMARY DOCUMENT 0001547522-16-000255 18850
2016-07-06 4 PRIMARY DOCUMENT 0001547522-16-000253 27492
2016-06-16 8-K/A AMENDMENT NO. 1 TO CURRENT REPORT 5.03,5.07,9.01 0001213900-16-014285 001-12934 161717533 34 53860
2016-06-15 8-K CURRENT REPORT 5.03,5.07 0001213900-16-014254 001-12934 161715747 34 40722
2016-05-23 8-K CURRENT REPORT 4.01 0001213900-16-013722 001-12934 161668046 34 18241
2016-05-11 8-K IMMUCELL CORPORATION 8-K 2.02,9.01 0001102624-16-002750 001-12934 161640308 34 26642 1
2016-05-11 10-Q QUARTERLY REPORT 0001213900-16-013173 001-12934 161639944 34 3416776 1
2016-04-28 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-16-012823 001-12934 161597245 34 215513
2016-04-15 4 PRIMARY DOCUMENT 0001547522-16-000244 4705
2016-04-15 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-16-012599 001-12934 161574149 34 216215
2016-04-05 3/A OWNERSHIP DOCUMENT 0001213900-16-012257 4073
2016-04-05 3 PRIMARY DOCUMENT 0001547522-16-000241 4121
2016-03-31 8-K CURRENT REPORT 1.01,2.03,9.01 0001213900-16-012164 001-12934 161543959 34 180146 1
2016-03-25 10-K ANNUAL REPORT 0001213900-16-011870 001-12934 161528870 34 4868181 1
2016-03-22 4 PRIMARY DOCUMENT 0001547522-16-000231 4767
2016-03-07 8-K CURRENT REPORT 4.01,9.01 0001213900-16-011368 001-12934 161488392 34 22722
2016-02-25 SC 13D/A SCHEDULE 13D 0001213900-16-011214 005-39373 161456425 34 43853
2016-02-10 8-K IMMUCELL CORPORATION 8-K 2.02,9.01 0001102624-16-002101 001-12934 161405748 34 26974
2016-02-03 8-K IMMUCELL CORPORATION 8-K 8.01,9.01 0001102624-16-002057 001-12934 161383587 34 18752
2016-02-03 SC 13D NORMAN H. PESSIN SC 13D 2-2-2016 (IMMUCELL CORPORATION) 0001140361-16-049936 005-39373 161383433 34 85985
2016-02-03 SC 13G/A NORTHPOINTE CAPITAL LLC 0001085146-16-002732 005-39373 161382766 34 27336
2016-02-01 4 PRIMARY DOCUMENT 0001547522-16-000208 6613
2016-02-01 4 PRIMARY DOCUMENT 0001547522-16-000206 4768
2016-02-01 4 PRIMARY DOCUMENT 0001547522-16-000204 4570
2016-02-01 4 PRIMARY DOCUMENT 0001547522-16-000202 4578
2016-01-29 8-K CURRENT REPORT 1.01,7.01,9.01 0001213900-16-010465 001-12934 161373060 34 246336
2016-01-29 424B5 PROSPECTUS 0001213900-16-010448 333-207635 161370997 33 512245
2016-01-29 8-K IMMUCELL CORPORATION 8-K 1.01,9.01 0001102624-16-002044 001-12934 161370889 34 18815
2016-01-28 424B5 PROSPECTUS 0001213900-16-010444 333-207635 161370139 33 517365
2016-01-07 8-K CURRENT REPORT 1.01 0001213900-16-009965 001-12934 161330234 34 29831
2015-12-22 8-K CURRENT REPORT 1.01 0001213900-15-009637 001-12934 151300839 34 191799
2015-11-13 4 PRIMARY DOCUMENT 0001547522-15-000180 5267
2015-11-12 10-Q QUARTERLY REPORT 0001213900-15-008486 001-12934 151224872 34 3774224 1
2015-11-12 8-K IMMUCELL CORPORATION 8-K 2.02,9.01 0001102624-15-001653 001-12934 151224813 34 27277
2015-11-10 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2015-11-10 14:00:00 9999999995-15-003017 333-207635 151220977 33 1662
2015-11-09 CORRESP filename1.htm 0001213900-15-008335 8911
2015-11-05 S-3/A AMENDMENT NO. 1 TO REGISTRATION STATEMENT 0001213900-15-008231 333-207635 151201430 33 296947
2015-10-27 S-3 REGISTRATION STATEMENT 0001213900-15-007957 333-207635 151179564 33 298986
2015-09-24 8-K CURRENT REPORT 1.01,2.03 0001213900-15-007254 001-12934 151123108 34 89120
2015-09-16 4 PRIMARY DOCUMENT 0001547522-15-000167 4572
2015-09-03 4 PRIMARY DOCUMENT 0001547522-15-000158 23226

Latest XBRL company facts

One latest value per concept from companyfacts (576 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 9.09M 2026-10-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
dei EntityPublicFloat Entity Public Float USD 50.60M 2025-06-27 2025 FY 10-K/A 2026-05-13 0001437749-26-016719
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 405,155 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001437749-26-013234
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 405,380 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001437749-26-013234
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 101 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001437749-26-013234
ffd NetFeeAmt NetFeeAmt USD 612.42 2026-11-12 S-8 2026-11-12 0001437749-26-036507
ffd TtlFeeAmt TtlFeeAmt USD 612.42 2026-11-12 S-8 2026-11-12 0001437749-26-036507
ffd TtlOfferingAmt TtlOfferingAmt USD 7.04M 2026-11-12 S-8 2026-11-12 0001437749-26-036507
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-11-12 S-8 2026-11-12 0001437749-26-036507
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 3.17M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent Accounts Payable and Accrued Liabilities USD 0 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 241,019 2014-09-30 2014 Q3 10-Q 2014-11-12 0001213900-14-007982
us-gaap AccountsPayableInterestBearingCurrent Accounts Payable, Interest-bearing, Current USD 54,385 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap AccountsPayableOtherCurrent Accounts Payable, Other, Current USD 420,139 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap AccountsPayableOtherCurrentAndNoncurrent Accounts Payable, Other USD 150,000 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065595
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 999,099 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap AccountsReceivableGrossCurrent Accounts Receivable, before Allowance for Credit Loss, Current USD 1.34M 2017-12-31 2017 FY 10-K 2018-03-29 0001213900-18-003621
us-gaap AccountsReceivableNet Accounts Receivable, after Allowance for Credit Loss USD 1.50M 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065595
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 3.37M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap AccountsReceivableNoncurrentAccruedInterestAfterAllowanceForCreditLoss Accounts Receivable, Noncurrent, Accrued Interest, after Allowance for Credit Loss USD 0 2024-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap AccountsReceivableRelatedPartiesCurrent Accounts Receivable, Related Parties, Current USD 46,426 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024080
us-gaap AccountsReceivableSale Accounts Receivable, Sale USD 6,101 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065595
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 367,233 2014-09-30 2014 Q3 10-Q 2014-11-12 0001213900-14-007982
us-gaap AccruedLiabilitiesForCommissionsExpenseAndTaxes Accrued Liabilities for Commissions, Expense and Taxes USD 150,000 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065595
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 1.05M 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 107,340 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 76,876 2019-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018473
us-gaap AccruedRoyaltiesCurrentAndNoncurrent Accrued Royalties USD 67,000 2016-01-04 2019 FY 10-K 2020-03-27 0001213900-20-007650
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 1.78M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap AccumulatedAmortizationDeferredFinanceCosts Accumulated Amortization, Debt Issuance Costs USD 19,822 2015-12-31 2015 FY 10-K 2016-03-25 0001213900-16-011870
us-gaap AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts Accumulated Amortization, Debt Issuance Costs, Noncurrent USD 13,603 2013-12-31 2013 FY 10-K 2014-03-26 0001144204-14-017813
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 18.84M 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease) USD 235,008 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-13 0001213900-17-011859
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -43,895 2019-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018473
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 36.15M 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065595
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 42.39M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap AdditionsToOtherAssetsAmount Additions to Other Assets, Amount USD 46.72M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap AdjustmentForAmortization Amortization USD 4,776 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0001213900-23-038529
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions APIC, Share-based Payment Arrangement, Recognition and Exercise USD 184,500 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-10 0001213900-16-018201
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 774,273 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 118,929 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 67,880 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD 398 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-26 0001213900-15-002097
us-gaap AdvertisingExpense Advertising Expense USD 109,506 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 774,273 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) USD 17,643 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-13 0001213900-17-011859
us-gaap AllowanceForDoubtfulAccountsReceivableRecoveries Accounts Receivable, Allowance for Credit Loss, Recovery USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap AllowanceForLoanAndLeaseLossRecoveryOfBadDebts Allowance for Loan and Lease Loss, Recovery of Bad Debts USD -14,483 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-13 0001213900-14-005701
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 10,446 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-13 0001213900-24-068245
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 21,612 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 9,404 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 784,661 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap AreaOfLand Area of Land sqft 14,300 2019-09-12 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap AreaOfRealEstateProperty Area of Real Estate Property sqft 7,100 2014-12-31 2014 FY 10-K 2015-03-26 0001213900-15-002097
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001437749-26-027668
us-gaap Assets Assets USD 47.96M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap AssetsCurrent Assets, Current USD 21.58M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap AssetsFairValueDisclosureNonrecurring Assets, Fair Value Disclosure, Nonrecurring (Deprecated 2018-01-31) USD 3.80M 2017-12-31 2017 FY 10-K 2018-03-29 0001213900-18-003621
us-gaap BuildingsAndImprovementsGross Buildings and Improvements, Gross USD 5.39M 2017-09-30 2017 Q3 10-Q 2017-11-13 0001213900-17-011859
us-gaap BusinessAcquisitionCostOfAcquiredEntityTransactionCosts Business Acquisition, Transaction Costs USD 97,000 2016-01-04 2019 FY 10-K 2020-03-27 0001213900-20-007650
us-gaap BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate Business Combination, Indemnification Assets, Amount as of Acquisition Date USD 368,000 2016-01-04 2019 FY 10-K 2020-03-27 0001213900-20-007650
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable USD 8,914 2018-12-31 2018 FY 10-K 2019-03-22 0001213900-19-004653
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill USD 191,000 2016-01-04 2019 FY 10-K 2020-03-27 0001213900-20-007650
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles USD 288,848 2016-03-31 2016 Q1 10-Q 2016-05-11 0001213900-16-013173
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory USD 113,000 2016-01-04 2019 FY 10-K 2020-03-27 0001213900-20-007650
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment USD 132,000 2016-01-04 2019 FY 10-K 2020-03-27 0001213900-20-007650
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net USD 96,000 2016-01-04 2019 FY 10-K 2020-03-27 0001213900-20-007650
us-gaap CapitalExpenditureDiscontinuedOperations Capital Expenditure, Discontinued Operations USD 446,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001213900-23-086092
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 50,316 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap Cash Cash USD 5,840 2022-03-31 2023 Q1 10-Q 2023-05-11 0001213900-23-038529
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 7.91M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 7.91M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 1.61M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-13 0001213900-20-011986
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 11.82M 2022-03-31 2022 Q1 10-Q/A 2022-11-21 0001213900-22-074049
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 6.00M 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 7.91M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 2.24M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 4.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap CashUninsuredAmount Cash, Uninsured Amount USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap CertificatesOfDepositAtCarryingValue Certificates of Deposit, at Carrying Value USD 996,495 2020-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016147
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 213,000 2012-12-31 2012 FY 10-K 2013-03-28 0001144204-13-018264
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.1 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 15.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 9.11M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 9.09M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap CommonStockValue Common Stock, Value, Issued USD 910,563 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -78,292 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016147
us-gaap ConcentrationRiskPercentage1 Concentration Risk, Percentage pure 0.1 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-11 0001213900-16-013173
us-gaap ConstructionAndDevelopmentCosts Construction and Development Costs (Deprecated 2018-01-31) USD 21.00M 2016-07-01 2016-09-30 2018 Q1 10-Q 2018-05-14 0001213900-18-006104
us-gaap ConstructionInProgressExpendituresIncurredButNotYetPaid Construction in Progress Expenditures Incurred but Not yet Paid USD 341,683 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024080
us-gaap ConstructionInProgressGross Construction in Progress, Gross USD 17.11M 2017-09-30 2017 Q3 10-Q 2017-11-13 0001213900-17-011859
us-gaap ConstructionPayableCurrentAndNoncurrent Construction Payable USD 6.23M 2017-09-30 2017 Q3 10-Q 2017-11-13 0001213900-17-011859
us-gaap ContractWithCustomerAssetNet Contract with Customer, Asset, after Allowance for Credit Loss USD 2.19M 2024-01-01 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap CostDepreciationAmortizationAndDepletion Cost, Depreciation, Amortization and Depletion USD 1.37M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 8.34M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 1.52M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-14 0001213900-18-006104
us-gaap CostOfRevenue Cost of Revenue USD 14.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap CurrentFederalStateAndLocalTaxExpenseBenefit Current Federal, State and Local, Tax Expense (Benefit) USD 11,570 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 708 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-28 0001144204-13-018264
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 10,056 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004072
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 11,570 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 9.54M 2025-09-30 2025 Q3 10-Q 2025-11-13 0001437749-25-034817
us-gaap DebtInstrumentConvertibleNumberOfEquityInstruments Debt Instrument, Convertible, Number of Equity Instruments CreditFacilities 5 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-22 0001213900-19-004653
us-gaap DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger pure 0.5 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-12 0001213900-14-007982
us-gaap DebtInstrumentFairValue Debt Instrument, Fair Value Disclosure USD 7.90M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 10,254 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD 97,522 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap DebtIssuanceCosts Debt Issuance Cost (Deprecated 2016-01-31) USD 34,125 2015-01-01 2015-09-30 2015 FY 10-K 2016-03-25 0001213900-16-011870
us-gaap DebtIssuanceCostsLineOfCreditArrangementsNet Debt Issuance Costs, Line of Credit Arrangements, Net USD 1.00M 2024-06-30 2024 Q2 10-Q 2024-08-13 0001213900-24-068245
us-gaap DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage pure 1 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-13 0001213900-24-068245
us-gaap DeferredCompensationLiabilityClassifiedNoncurrent Deferred Compensation Liability, Classified, Noncurrent USD 23,370 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024080
us-gaap DeferredCompensationLiabilityCurrent Deferred Compensation Liability, Current USD 19,588 2015-12-31 2015 FY 10-K 2016-03-25 0001213900-16-011870
us-gaap DeferredDiscountsFinanceChargesAndInterestIncludedInReceivables Deferred Discounts, Finance Charges and Interest Included in Receivables USD 0 2024-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -220,758 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap DeferredFederalStateAndLocalTaxExpenseBenefit Deferred Federal, State and Local, Tax Expense (Benefit) USD -332,646 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap DeferredFinanceCostsCurrentGross Debt Issuance Costs, Gross, Current USD 173,305 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap DeferredFinanceCostsGross Debt Issuance Costs, Gross USD 5,721 2022-03-31 2022 Q1 10-Q/A 2022-11-21 0001213900-22-074049
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 28,036 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 296,347 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-27 0001213900-20-007650
us-gaap DeferredIncomeTaxesAndTaxCredits Deferred Income Taxes and Tax Credits USD -14,631 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016147
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap DeferredOtherTaxExpenseBenefit Deferred Other Tax Expense (Benefit) USD 332,646 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 24,100 2017-12-31 2018 FY 10-K 2019-03-22 0001213900-19-004653
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -111,888 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 965,000 2004-12-31 2018 Q3 10-Q 2018-11-13 0001213900-18-015491
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 4.93M 2025-12-31 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 266,078 2014-12-31 2014 FY 10-K 2015-03-26 0001213900-15-002097
us-gaap DeferredTaxAssetsInvestments Deferred Tax Assets, Investments USD 820,000 2017-12-31 2017 FY 10-K 2018-03-29 0001213900-18-003621
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 0 2015-12-31 2015 FY 10-K 2016-03-25 0001213900-16-011870
us-gaap DeferredTaxAssetsNetNoncurrent Deferred Tax Assets, Net of Valuation Allowance, Noncurrent USD 472,726 2017-12-31 2018 FY 10-K 2019-03-22 0001213900-19-004653
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 3.67M 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 359,764 2017-12-31 2017 FY 10-K 2018-03-29 0001213900-18-003621
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 927,108 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 22,443 2024-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004072
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 1.83M 2024-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004072
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 901,466 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness Deferred Tax Assets, Tax Credit Carryforwards, General Business USD 673,233 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024080
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsOther Deferred Tax Assets, Tax Credit Carryforwards, Other USD 763,350 2020-12-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026068
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 52,872 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation USD 53,179 2020-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018473
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other USD 727,410 2024-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004072
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 6,289 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016147
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 74,110 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent USD 14,632 2019-12-31 2019 FY 10-K 2020-03-27 0001213900-20-007650
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 121,718 2024-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004072
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 4.93M 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital Deferred Taxes, Business Combination, Valuation Allowance, Allocated to Contributed Capital USD 820,000 2018-09-30 2018 Q3 10-Q 2018-11-13 0001213900-18-015491
us-gaap DeferredTaxExpenseFromStockOptionsExercised Deferred Tax Expense from Stock Options Exercised USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-26 0001213900-15-002097
us-gaap DeferredTaxLiabilitiesCurrent Deferred Tax Liabilities, Net, Current USD 19,588 2015-12-31 2017 Q2 10-Q 2017-08-14 0001213900-17-008652
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 57,574 2017-03-31 2017 Q1 10-Q 2017-05-11 0001213900-17-004937
us-gaap DeferredTaxLiabilitiesPrepaidExpenses Deferred Tax Liabilities, Prepaid Expenses USD -15,143 2013-12-31 2013 FY 10-K 2014-03-26 0001144204-14-017813
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 950,593 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostChangeDueToSubsequentInterimMeasurementWeightedAverageExpectedLongTermRateOfReturnOnPlanAssets Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Change Due to Subsequent Interim Measurement, Weighted-Average Expected Long-term Rate of Return on Plan Assets pure 0.5 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097450
us-gaap DefinedBenefitPlanBenefitsPaid Defined Benefit Plan, Benefits Paid (Deprecated 2017-01-31) USD 18,709 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-11 0001213900-17-004937
us-gaap DefinedBenefitPlanPlanAssetsBenefitsPaid Defined Benefit Plan, Plan Assets, Benefits Paid USD 92,800 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.5 2012-01-01 2012-07-31 2013 FY 10-K 2014-03-26 0001144204-14-017813
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.04 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-26 0001213900-15-002097
us-gaap DefinedContributionPlanMaximumAnnualContributionPerEmployeePercent Defined Contribution Plan, Maximum Annual Contribution Per Employee, Percent (Deprecated 2013-01-31) pure 0.04 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-28 0001144204-13-018264
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.5 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-26 0001213900-15-002097
us-gaap DepositAssets Deposit Assets USD 0 2016-03-31 2016 Q1 10-Q 2016-05-11 0001213900-16-013173
us-gaap Depreciation Depreciation USD 1.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 1.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap DerivativeAssetsNoncurrent Derivative Asset, Noncurrent USD 40,209 2018-12-31 2019 FY 10-K 2020-03-27 0001213900-20-007650
us-gaap DerivativeFixedInterestRate Derivative, Fixed Interest Rate pure 0.05 2021-06-30 2024 Q2 10-Q 2024-08-13 0001213900-24-068245
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 58,526 2019-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018473
us-gaap DueFromRelatedParties Due from Related Parties USD 450,000 2018-12-31 2019 FY 10-K 2020-03-27 0001213900-20-007650
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0.52 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0.51 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.018 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.323 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap EffectiveIncomeTaxRateReconciliationDeductionsOther Effective Income Tax Rate Reconciliation, Deduction, Other, Percent pure 0.016 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018473
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.34 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-29 0001213900-18-003621
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent pure 0.21 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024080
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.029 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018473
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.003 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024080
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0.002 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004072
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 28,214 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.028 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.078 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.01 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001437749-25-034817
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent pure 0.01 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.057 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap EffectiveIncomeTaxRateReconciliationTaxExemptIncome Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent pure 0.21 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004072
us-gaap EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal Effective Income Tax Rate Reconciliation, Tax Settlement, State and Local, Percent pure 0.053 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-30 0001213900-17-003009
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount USD 95,560 2014-12-31 2014 FY 10-K 2015-03-26 0001213900-15-002097
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 875,883 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased Employee Stock Ownership Plan (ESOP), Weighted Average Purchase Price of Shares Purchased USD/shares 70 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097450
us-gaap EquityClassifiedWrittenCallOptionModificationDecreaseInNetIncomeLossToCommonShareholderAmount EquityClassifiedWrittenCallOptionModificationDecreaseInNetIncomeLossToCommonShareholderAmount USD 222,379 2022-01-01 2022-06-30 2022 Q3 10-Q 2022-11-21 0001213900-22-074215
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.2 2014-12-31 2014 FY 10-K 2015-03-26 0001213900-15-002097
us-gaap EscrowDeposit Escrow Deposit USD 34,264 2017-12-31 2017 FY 10-K 2018-03-29 0001213900-18-003621
us-gaap ExcessTaxBenefitFromShareBasedCompensationFinancingActivities Excess Tax Benefit from Share-based Compensation, Financing Activities USD 78,430 2021-07-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001213900-21-059332
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-14 0001213900-18-006104
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.57 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-14 0001213900-18-006104
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.025 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-14 0001213900-18-006104
us-gaap FairValueLiabilitiesMeasuredOnRecurringBasisObligations Obligations, Fair Value Disclosure USD 9.14M 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016147
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap FairValueNetAssetLiability Fair Value, Net Asset (Liability) USD 7.95M 2020-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016147
us-gaap FederalHomeLoanBankBorrowingsFairValueDisclosure Federal Home Loan Bank Borrowings, Fair Value Disclosure USD 10.80M 2023-09-30 2023 Q3 10-Q 2023-11-13 0001213900-23-086092
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 1.14M 2021-09-30 2021 Q3 10-Q 2021-11-15 0001213900-21-059332
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 191,040 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 19,104 2019-12-31 2019 FY 10-K 2020-03-27 0001213900-20-007650
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 19,104 2018-12-31 2018 FY 10-K 2019-03-22 0001213900-19-004653
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 19,104 2019-12-31 2019 FY 10-K 2020-03-27 0001213900-20-007650
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 19,104 2019-12-31 2019 FY 10-K 2020-03-27 0001213900-20-007650
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 19,104 2019-12-31 2019 FY 10-K 2020-03-27 0001213900-20-007650
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 19,104 2019-12-31 2019 FY 10-K 2020-03-27 0001213900-20-007650
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 19,104 2019-12-31 2019 FY 10-K 2020-03-27 0001213900-20-007650
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 191,040 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap FurnitureAndFixturesGross Furniture and Fixtures, Gross USD 697,585 2017-09-30 2017 Q3 10-Q 2017-11-13 0001213900-17-011859
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 4,264 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 700,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-27 0001213900-20-007650
us-gaap GainLossOnDispositionOfProperty Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) USD -37 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-14 0001144204-13-028498
us-gaap GainLossOnSaleOfProperty Gain (Loss) on Disposition of Oil and Gas and Timber Property USD 700,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-27 0001213900-20-007650
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 4,264 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 3.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap Goodwill Goodwill USD 95,557 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap GrossProfit Gross Profit USD 10.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap HeldToMaturitySecurities Debt Securities, Held-to-maturity USD 5.48M 2016-12-31 2017 FY 10-K 2018-03-29 0001213900-18-003621
us-gaap HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain USD 2,073 2016-12-31 2017 FY 10-K 2018-03-29 0001213900-18-003621
us-gaap HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss USD 59 2016-12-31 2017 FY 10-K 2018-03-29 0001213900-18-003621
us-gaap HeldToMaturitySecuritiesFairValue Debt Securities, Held-to-maturity, Fair Value USD 5.45M 2016-12-31 2017 FY 10-K 2018-03-29 0001213900-18-003621
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -1.03M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 4.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap IncomeTaxesPaid Income Taxes Paid USD 7,293 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004072
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 83,109 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 48 2013-09-30 2013 Q3 10-Q 2013-11-13 0001144204-13-060883
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 41,237 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability USD 71,000 2017-12-01 2017-12-22 2019 Q3 10-Q 2019-11-12 0001213900-19-022739
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 10,691 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap IncomeTaxReceivable Income Taxes Receivable USD 0 2014-12-31 2014 FY 10-K 2015-03-26 0001213900-15-002097
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 332,646 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -215,976 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD -216,773 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018473
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 1,723 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-29 0001213900-18-003621
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD -42,664 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-25 0001213900-16-011870
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 30,121 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018473
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 4,619 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004072
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 16,287 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018473
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -79,693 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 116,091 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004072
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 58,901 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap IncomeTaxReconciliationTaxSettlementsStateAndLocal Effective Income Tax Rate Reconciliation, Tax Settlement, State and Local, Amount USD 109,112 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-30 0001213900-17-003009
us-gaap IncreaseDecreaseInAccountsAndOtherReceivables Increase (Decrease) in Accounts and Other Receivables USD 105,985 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001213900-23-086092
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 4,835 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-12 0001213900-14-007982
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 840,696 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 42,770 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-13 0001213900-17-011859
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -45,250 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD 222,379 2022-01-01 2022-03-31 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 74,157 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-12 0001213900-14-007982
us-gaap IncreaseDecreaseInAccruedSalaries Increase (Decrease) in Accrued Salaries USD 32,568 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-13 0001213900-17-011859
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -24,100 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-27 0001213900-20-007650
us-gaap IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments Increase (Decrease) in Fair Value of Interest Rate Fair Value Hedging Instruments (Deprecated 2012-01-31) USD -5,610 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-14 0001144204-12-028352
us-gaap IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1 Increase (Decrease) in Fair Value of Interest Rate Fair Value Hedging Instruments USD 58,835 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065595
us-gaap IncreaseDecreaseInIncomeTaxes Increase (Decrease) in Income Taxes USD 300 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-28 0001144204-13-018264
us-gaap IncreaseDecreaseInIncomeTaxesReceivable Increase (Decrease) in Income Taxes Receivable USD -48 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-26 0001213900-15-002097
us-gaap IncreaseDecreaseInIntangibleAssetsCurrent Increase (Decrease) in Intangible Assets, Current USD 288,848 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-11 0001213900-16-013173
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 589,678 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap IncreaseDecreaseInOperatingCapital Increase (Decrease) in Operating Capital USD -1.29M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-13 0001213900-17-011859
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD 154,246 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-13 0001213900-17-011859
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD 20,251 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap IncreaseDecreaseInOtherDeposits Increase (Decrease) in Other Deposits USD 8,920 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-11 0001213900-16-013173
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 270,620 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-11 0001213900-16-013173
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -7,869 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD -19,157 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-13 0001213900-17-011859
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -19,406 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 64,155 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-13 0001213900-17-011859
us-gaap IncreaseDecreaseInRawMaterialsPackagingMaterialsAndSuppliesInventories Increase (Decrease) in Raw Materials, Packaging Materials and Supplies Inventories USD 189,163 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-13 0001213900-17-011859
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD -358,806 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-13 0001213900-18-010819
us-gaap IncreaseDecreaseInSecurityDeposits Increase (Decrease) in Security Deposits USD 287,681 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-13 0001213900-17-011859
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 123,675 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap InsuranceRecoveries Insurance Recoveries USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap InsuredEventGainLoss Insured Event, Gain (Loss) USD 250,000 2023-07-01 2023-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap IntangibleAssetsCurrent Intangible Assets, Current USD 191,040 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042925
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 42,984 2023-09-30 2023 Q3 10-Q 2023-11-13 0001213900-23-086092
us-gaap InterestCostsIncurred Interest Costs Incurred USD 5,037 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097450
us-gaap InterestExpense Interest Expense USD 432,529 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097450
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 287,869 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap InterestExpenseOther Interest Expense, Other USD 314,359 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016147
us-gaap InterestIncomeOther Interest Income, Other USD 85,582 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 123,034 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-13 0001213900-17-011859
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 282,056 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap InterestRevenueExpenseNet Interest Revenue (Expense), Net USD -252,723 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 1.20M 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap InventoryFinishedGoodsAndWorkInProcessNetOfReserves Inventory, Finished Goods and Work in Process, Net of Reserves USD 305,334 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065595
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 2.96M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap InventoryNet Inventory, Net USD 9.86M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 1.51M 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 1.87M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 233,665 2026-06-30 2026 Q2 10-Q 2026-08-13 0001437749-26-027668
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 5.58M 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 5.03M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap InventoryWriteDown Inventory Write-down USD 406,565 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004072
us-gaap InvestmentCompanyPurchasePremiumPerShare InvestmentCompanyPurchasePremiumPerShare USD/shares 70 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097450
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 179,670 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap Land Land USD 518,998 2017-09-30 2017 Q3 10-Q 2017-11-13 0001213900-17-011859
us-gaap LandUnderPurchaseOptionsRecorded Land under Purchase Options, Recorded USD 20,500 2016-12-31 2017 Q2 10-Q 2017-08-14 0001213900-17-008652
us-gaap LeaseCost Lease, Cost USD 478,715 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 6.96M 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 5.16M 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 346,874 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 375,465 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 368,397 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 360,885 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 353,812 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 86,001 2025-09-30 2025 Q3 10-Q 2025-11-13 0001437749-25-034817
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 2.87M 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap Liabilities Liabilities USD 15.18M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 47.96M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap LiabilitiesCurrent Liabilities, Current USD 4.68M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 10.50M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap LiabilitiesSubjectToCompromiseEarlyContractTerminationFees Liabilities Subject to Compromise, Early Contract Termination Fees USD 100,000 2019-06-30 2019 Q2 10-Q 2019-08-12 0001213900-19-015331
us-gaap LicenseCosts License Costs (Deprecated 2018-01-31) USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-25 0001213900-16-011870
us-gaap LineOfCredit Long-term Line of Credit USD 1.00M 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap LineOfCreditFacilityFairValueOfAmountOutstanding Line of Credit Facility, Fair Value of Amount Outstanding USD 1.00M 2020-09-30 2020 Q3 10-Q 2020-11-12 0001213900-20-036536
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 1.00M 2026-06-30 2026 Q2 10-Q 2026-08-13 0001437749-26-027668
us-gaap LinesOfCreditCurrent Line of Credit, Current USD 1.00M 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065595
us-gaap LoansPayableToBankCurrent Loans Payable to Bank, Current USD 1.09M 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065595
us-gaap LongTermDebt Long-term Debt USD 7.90M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap LongTermDebtAndCapitalLeaseObligations Long-term Debt and Lease Obligation USD 8.65M 2025-03-31 2025 Q1 10-Q 2025-05-14 0001213900-25-043287
us-gaap LongTermDebtAndCapitalLeaseObligationsCurrent Long-term Debt and Lease Obligation, Current USD 1.52M 2025-03-31 2025 Q1 10-Q 2025-05-14 0001213900-25-043287
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 1.38M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months USD 571,977 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026068
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 1.62M 2025-09-30 2025 Q3 10-Q 2025-11-13 0001437749-25-034817
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive Long-term Debt, Maturities, Repayments of Principal in Rolling after Year Five USD 5.09M 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026068
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive Long-term Debt, Maturities, Repayments of Principal in Rolling Year Five USD 980,732 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026068
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour Long-term Debt, Maturities, Repayments of Principal in Rolling Year Four USD 944,380 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026068
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFourAndFive Long-term Debt, Maturities, Repayments of Principal in Rolling Year Four and Five USD 984,076 2020-09-30 2020 Q3 10-Q 2020-11-12 0001213900-20-036536
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree Long-term Debt, Maturities, Repayments of Principal in Rolling Year Three USD 910,618 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026068
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo Long-term Debt, Maturities, Repayments of Principal in Rolling Year Two USD 812,206 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026068
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 4.32M 2025-03-31 2025 Q1 10-Q 2025-05-14 0001213900-25-043287
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 782,667 2025-09-30 2025 Q3 10-Q 2025-11-13 0001437749-25-034817
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 821,163 2025-09-30 2025 Q3 10-Q 2025-11-13 0001437749-25-034817
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 1.24M 2025-09-30 2025 Q3 10-Q 2025-11-13 0001437749-25-034817
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 394,626 2025-09-30 2025 Q3 10-Q 2025-11-13 0001437749-25-034817
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 6.52M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap LongTermDebtPercentageBearingFixedInterestRate Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate pure 0.036 2022-03-31 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap LongTermInvestments Long-term Investments USD 489,648 2015-12-31 2016 FY 10-K 2017-03-30 0001213900-17-003009
us-gaap LongTermLoansFromBank Loans Payable to Bank, Noncurrent USD 8.64M 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065595
us-gaap LossContingencyReceivable Loss Contingency, Receivable USD 250,000 2023-09-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap MachineryAndEquipmentGross Machinery and Equipment, Gross USD 5.51M 2017-09-30 2017 Q3 10-Q 2017-11-13 0001213900-17-011859
us-gaap MarketRiskBenefitBenefitPayment MarketRiskBenefitBenefitPayment USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016147
us-gaap MortgageLoansOnRealEstatePeriodicPaymentTermsBalloonPaymentAmount Mortgage Loans on Real Estate, Periodic Payment Terms, Balloon Payment Amount (Deprecated 2013-01-31) USD 451,885 2010-09-30 2013 Q1 10-Q 2013-05-14 0001144204-13-028498
us-gaap MortgageLoansOnRealEstatePeriodicPaymentTermsBalloonPaymentToBeReceived Mortgage Loans on Real Estate, Periodic Payment Terms, Balloon Payment to be Received USD 451,885 2010-09-30 2013 Q3 10-Q 2013-11-13 0001144204-13-060883
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -994,003 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 3.90M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-13 0001213900-17-011859
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -2.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -7.59M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-13 0001213900-17-011859
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 7.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 845,116 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-13 0001213900-17-011859
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 4.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD -3.69M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065595
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD 4.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -92,010 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap NotionalAmountOfInterestRateDerivatives Notional Amount of Interest Rate Derivatives (Deprecated 2013-01-31) USD 1.00M 2012-12-31 2012 FY 10-K 2013-03-28 0001144204-13-018264
us-gaap NumberOfOperatingSegments Number of Operating Segments pure 2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap NumberOfReportableSegments Number of Reportable Segments pure 2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap OperatingExpenses Operating Expenses USD 5.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 4.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap OperatingLeaseCost Operating Lease, Cost USD 404,529 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 4.10M 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 124,235 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 3.99M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap OperatingLeasePayments Operating Lease, Payments USD 689,375 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 4.34M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 10,000 2020-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018473
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 25,000 2020-09-30 2020 Q3 10-Q 2020-11-12 0001213900-20-036536
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 20,000 2020-09-30 2020 Q3 10-Q 2020-11-12 0001213900-20-036536
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 15,000 2020-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018473
us-gaap OperatingLeasesFutureMinimumPaymentsReceivable Operating Leases, Future Minimum Payments Receivable USD 1.52M 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026068
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableCurrent Operating Leases, Future Minimum Payments Receivable, Current USD 119,547 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026068
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears Operating Leases, Future Minimum Payments Receivable, in Five Years USD 171,383 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026068
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInFourYears Operating Leases, Future Minimum Payments Receivable, in Four Years USD 168,210 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026068
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears Operating Leases, Future Minimum Payments Receivable, in Three Years USD 165,120 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026068
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears Operating Leases, Future Minimum Payments Receivable, in Two Years USD 162,102 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026068
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableRemainderOfFiscalYear Operating Leases, Future Minimum Payments Receivable, Remainder of Fiscal Year USD 1.21M 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026068
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableThereafter Operating Leases, Future Minimum Payments Receivable, Thereafter USD 734,304 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026068
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 5,000 2020-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018473
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.066 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 2.65M 2020-12-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026068
us-gaap OperatingLossCarryforwardsValuationAllowance Operating Loss Carryforwards, Valuation Allowance USD 78,000 2015-12-31 2016 Q3 10-Q 2016-11-10 0001213900-16-018201
us-gaap OtherAccountsPayableAndAccruedLiabilities Other Accounts Payable and Accrued Liabilities USD 773,061 2024-06-30 2024 Q2 10-Q 2024-08-13 0001213900-24-068245
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 21,215 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap OtherAssets Other Assets USD 0 2013-12-31 2013 FY 10-K 2014-03-26 0001144204-14-017813
us-gaap OtherAssetsCurrent Other Assets, Current USD 57,655 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028718
us-gaap OtherAssetsFairValueDisclosure Other Assets, Fair Value Disclosure USD 40,209 2018-12-31 2019 FY 10-K 2020-03-27 0001213900-20-007650
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 29,817 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap OtherCommitment Other Commitment USD 377,000 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 43,895 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016147
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 43,895 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016147
us-gaap OtherCostAndExpenseOperating Other Cost and Expense, Operating USD 2.60M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042925
us-gaap OtherCostOfOperatingRevenue Other Cost of Operating Revenue USD 146,240 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065595
us-gaap OtherDeferredCompensationArrangementsLiabilityCurrent Other Deferred Compensation Arrangements, Liability, Current USD 300,000 2025-03-31 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap OtherIncome Other Income USD 11,925 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap OtherLiabilities Other Liabilities USD 9.26M 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065595
us-gaap OtherLiabilitiesFairValueDisclosure Other Liabilities, Fair Value Disclosure USD 58,526 2019-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018473
us-gaap OtherLongTermDebt Other Long-term Debt USD 2.33M 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap OtherLongTermInvestments Other Long-term Investments USD 20.80M 2017-09-30 2017 Q3 10-Q 2017-11-13 0001213900-17-011859
us-gaap OtherNoncashExpense Other Noncash Expense USD 95,724 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028718
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 76,773 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap OtherNoncashIncomeTaxExpense Other Noncash Income Tax Expense USD 563,252 2018-07-01 2018-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 479,590 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001213900-20-036536
us-gaap OtherNonoperatingGainsLosses Other Nonoperating Gains (Losses) USD -75 2018-04-01 2018-06-30 2019 Q2 10-Q 2019-08-12 0001213900-19-015331
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -405,610 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097450
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD -113,092 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001213900-23-086092
us-gaap OtherPaymentsToAcquireBusinesses Other Payments to Acquire Businesses USD 4,892 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-14 0001213900-17-008652
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 433,237 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065595
us-gaap OtherReceivables Other Receivables USD 250,000 2023-09-30 2024 FY 10-K 2025-03-28 0001013762-25-004072
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 47,614 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 3.90M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004072
us-gaap OtherShortTermInvestments Other Short-term Investments USD 996,495 2020-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016147
us-gaap OtherTaxExpenseBenefit Other Tax Expense (Benefit) USD 7,672 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024080
us-gaap ParticipatingMortgageLoansUnamortizedDebtDiscountAmount Participating Mortgage Loans, Unamortized Debt Discount, Amount USD 2.00M 2022-03-31 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap PaymentForContingentConsiderationLiabilityInvestingActivities Payment for Contingent Consideration Liability, Investing Activities USD 8,914 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018473
us-gaap PaymentsForConstructionInProcess Payments for Construction in Process USD 650,733 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-10 0001213900-16-018201
us-gaap PaymentsForLoans Payments for Loans USD 45,533 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 115,127 2023-10-31 2023 Q3 10-Q 2023-11-13 0001213900-23-086092
us-gaap PaymentsForProceedsFromShortTermInvestments Payments for (Proceeds from) Short-term Investments USD -996,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024080
us-gaap PaymentsForRent Payments for Rent USD 248,743 2025-01-01 2025-07-31 2025 Q3 10-Q 2025-11-13 0001437749-25-034817
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 532,000 2015-12-29 2016-01-04 2019 FY 10-K 2020-03-27 0001213900-20-007650
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 1.99M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016147
us-gaap PaymentsToAcquireLongtermInvestments Payments to Acquire Long-term Investments USD 496,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-26 0001213900-15-002097
us-gaap PaymentsToAcquireOtherProductiveAssets Payments to Acquire Other Productive Assets USD 115,127 2023-01-01 2023-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097450
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 77,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-13 0001213900-18-015491
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 2.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 10.12M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-27 0001213900-20-007650
us-gaap PrepaidExpenseAndOtherAssets Prepaid Expense and Other Assets USD 577,440 2016-03-31 2016 Q1 10-Q 2016-05-11 0001213900-16-013173
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 432,267 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 384,653 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 1.00M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0001213900-23-038529
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 1.00M 2010-07-01 2010-09-30 2013 Q3 10-Q 2013-11-13 0001144204-13-060883
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 1.03M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-22 0001213900-19-004653
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 10.00M 2015-10-01 2015-10-28 2022 Q1 10-Q/A 2022-11-21 0001213900-22-074049
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 2.00M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004072
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments Proceeds from Maturities, Prepayments and Calls of Short-term Investments USD 1.97M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-13 0001213900-20-011986
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 600,000 2011-01-01 2011-03-31 2016 FY 10-K 2017-03-30 0001213900-17-003009
us-gaap ProceedsFromOtherDebt Proceeds from Other Debt USD 3.00M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001213900-23-086092
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD 600,000 2011-01-01 2011-03-31 2012 Q3 10-Q 2012-11-13 0001144204-12-061178
us-gaap ProceedsFromRepaymentsOfOtherDebt Proceeds from (Repayments of) Other Debt USD -19,306 2022-01-01 2022-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065595
us-gaap ProceedsFromSaleOfOtherProductiveAssets Proceeds from Sale of Other Productive Assets USD 15 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0001213900-23-038529
us-gaap ProceedsFromSaleOfOtherPropertyPlantAndEquipment Proceeds from Sale of Other Property, Plant, and Equipment USD 91 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065595
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 6.98M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065595
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 10,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap ProceedsFromSaleOfShortTermInvestments Proceeds from Sale of Short-term Investments USD 600 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-13 0001213900-20-011986
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 215,659 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 183 2017-01-01 2017-09-30 2018 Q3 10-Q 2018-11-13 0001213900-18-015491
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 513,287 2022-01-01 2022-03-31 2022 Q1 10-Q/A 2022-11-21 0001213900-22-074049
us-gaap PropertyPlantAndEquipmentDisposals Property, Plant and Equipment, Disposals USD 3.08M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 39.91M 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease Property, Plant and Equipment, Gross, Period Increase (Decrease) USD 13.93M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-13 0001213900-17-011859
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 21.92M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap PropertyPlantAndEquipmentOther Property, Plant and Equipment, Other, Gross USD 25.26M 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap PropertyPlantAndEquipmentOtherAccumulatedDepreciation Property, Plant and Equipment, Other, Accumulated Depreciation USD 9.50M 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap PropertyPlantAndEquipmentOtherNet Property, Plant and Equipment, Other, Net USD 15.76M 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap PropertyPlantAndEquipmentSalvageValuePercentage Property, Plant and Equipment, Salvage Value, Percentage pure 0.86 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap PurchaseObligation Purchase Obligation USD 550,000 2014-12-31 2014 FY 10-K 2015-03-26 0001213900-15-002097
us-gaap PurchaseObligationDueInNextTwelveMonths Purchase Obligation, to be Paid, Year One USD 326,000 2014-12-31 2014 FY 10-K 2015-03-26 0001213900-15-002097
us-gaap RelatedPartyTaxExpenseDueFromAffiliatesCurrent Related Party Tax Expense, Due from Affiliates, Current USD 25,646 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042925
us-gaap RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty Related Party Transaction, Expenses from Transactions with Related Party USD 975 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018473
us-gaap RelatedPartyTransactionPurchasesFromRelatedParty Related Party Transaction, Purchases from Related Party USD 462,003 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party USD 222,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-21 0001213900-22-074215
us-gaap RepaymentsOfBankDebt Repayments of Bank Debt USD 3.41M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001437749-25-034817
us-gaap RepaymentsOfDebt Repayments of Debt USD 1.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap RepaymentsOfDebtAndCapitalLeaseObligations Repayments of Debt and Lease Obligation USD 768,271 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016147
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 2.00M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004072
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 614,111 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 1.45M 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065595
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 1.40M 2020-09-30 2020 Q3 10-Q 2020-11-12 0001213900-20-036536
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -10.47M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 25.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 14.51M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap RevenueFromRelatedParties Revenue from Related Parties USD 587,677 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024080
us-gaap RevenueRemainingPerformanceObligationPercentage Revenue, Remaining Performance Obligation, Percentage pure 1 2025-03-31 2025 Q1 10-Q 2025-05-14 0001213900-25-043287
us-gaap Revenues Revenues USD 14.51M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 95,719 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap RoyaltyExpense Royalty Expense USD 36,000 2016-01-01 2018-12-31 2019 FY 10-K 2020-03-27 0001213900-20-007650
us-gaap RoyaltyIncomeNonoperating Royalty Income, Nonoperating USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-25 0001213900-16-011870
us-gaap RoyaltyRevenue Royalty Revenue (Deprecated 2018-01-31) USD 67,000 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-10 0001213900-16-018201
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 1.23M 2024-01-01 2024-12-31 2025 Q2 10-Q 2025-08-14 0001213900-25-076635
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 8.25 2021-04-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097450
us-gaap SalesReturnsGoods Sales Returns, Goods (Deprecated 2018-01-31) USD 10,720 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-13 0001213900-17-011859
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 2.88M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-14 0001213900-18-006104
us-gaap SecuredDebt Secured Debt USD 2.10M 2010-09-30 2015 Q2 10-Q 2015-08-13 0001213900-15-006046
us-gaap SecurityDeposit Security Deposit USD 800 2020-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016147
us-gaap SegmentExpenditureAdditionToLongLivedAssets SegmentExpenditureAdditionToLongLivedAssets USD 2.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 3.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 774,273 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 2.26 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-26 0001213900-15-002097
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.54 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.038 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 393,527 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 350,500 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 7.27 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 22,200 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001437749-25-034817
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 6.72 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001437749-25-034817
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 135,500 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 86,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004072
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 288,260 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 3.13 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 416,983 2025-09-30 2025 Q3 10-Q 2025-11-13 0001437749-25-034817
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares shares 118,500 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001437749-25-034817
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value USD/shares 3.68 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001437749-25-034817
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 2.76 2025-09-30 2025 Q3 10-Q 2025-11-13 0001437749-25-034817
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 38,234 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 801,760 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 6.2 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 355,293 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 5.36 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 14,200 2025-09-30 2025 Q3 10-Q 2025-11-13 0001437749-25-034817
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 451,260 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 6.45 2025-03-31 2025 Q1 10-Q 2025-05-14 0001213900-25-043287
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 107,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001437749-25-034817
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 4.36 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001437749-25-034817
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased USD/shares 70 2014-12-31 2014 FY 10-K 2015-03-26 0001213900-15-002097
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 4.81 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 6.77 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 5.79 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit USD/shares 4.25 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-26 0001213900-15-002097
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit USD/shares 4.8 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-26 0001213900-15-002097
us-gaap SharePrice Share Price USD/shares 8.08 2016-01-06 2017 Q2 10-Q 2017-08-14 0001213900-17-008652
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 5.87 2021-04-30 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap ShortTermBorrowings Short-term Debt USD 9.85M 2024-06-30 2024 Q2 10-Q 2024-08-13 0001213900-24-068245
us-gaap ShorttermDebtAverageOutstandingAmount Short-term Debt, Average Outstanding Amount USD 1.00M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-13 0001213900-24-068245
us-gaap ShortTermInvestments Short-term Investments USD 996,495 2020-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016147
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 32.77M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap StockIssuedDuringPeriodSharesIssuedForCash Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) shares 30,000 2011-01-01 2011-12-31 2012 FY 10-K 2013-03-28 0001144204-13-018264
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 4.55M 2016-02-01 2021-04-30 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap StockIssuedDuringPeriodSharesPeriodIncreaseDecrease Stock Issued During Period, Shares, Period Increase (Decrease) shares 500,000 2001-06-01 2001-06-30 2012 FY 10-K 2013-03-28 0001144204-13-018264
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2025-01-01 2025-03-31 2026 Q1 10-Q 2026-05-14 0001437749-26-017045
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 281,446 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 1.03M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-22 0001213900-19-004653
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 215,659 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense Stock Issued, Value, Stock Options Exercised, Net of Tax Benefit (Expense) USD 25,706 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-30 0001213900-17-003009
us-gaap StockOptionExercisePriceIncrease Stock Option, Exercise Price, Increase USD/shares 9.39 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028718
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 82,627 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-28 0001144204-13-018264
us-gaap TaxBenefitFromStockOptionsExercised Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) USD 6,842 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-14 0001144204-12-028352
us-gaap TaxBenefitFromStockOptionsExercised1 Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) USD 0 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-14 0001144204-13-028498
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 15,261 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 50,387 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap TreasuryStockShares Treasury Stock, Shares shares 67,301 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024080
us-gaap TreasuryStockValue Treasury Stock, Value USD 147,233 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065595
us-gaap UnamortizedDebtIssuanceExpense Unamortized Debt Issuance Expense USD 26,489 2013-12-31 2013 FY 10-K 2014-03-26 0001144204-14-017813
us-gaap USGovernmentSecuritiesAtCarryingValue US Government Securities, at Carrying Value USD 0 2022-03-31 2022 Q1 10-Q/A 2022-11-21 0001213900-22-074049
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 315,725 2018-07-01 2018-09-30 2018 Q3 10-Q 2018-11-13 0001213900-18-015491
us-gaap VariableLeaseCost Variable Lease, Cost USD 74,186 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010339
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 9.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 7.22M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026068
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 9.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036588

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →